Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FN3QQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $74,636
Award facts
- Contract value 100% obligated
- $74,636.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $74,636.43 for RINVOQ ER 45 mg tablets (28-count units) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, fulfills this delivery order under its broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026.
This delivery order represents a component of AmerisourceBergen's comprehensive pharmaceutical supply relationship with the Defense Logistics Agency's Medical Supply Chain, which supports military healthcare systems and other federal medical procurement needs. RINVOQ (upadacitinib), a specialty medication, reflects the company's role in delivering brand-name therapeutics across multiple therapeutic domains to support defense and veteran healthcare operations. The contract exemplifies the Defense Logistics Agency's approach to maintaining reliable pharmaceutical supply chains through established vendor relationships and flexible delivery mechanisms.
Quick answers
Who was awarded contract SPE2DB25FN3QQ?
SPE2DB25FN3QQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FN3QQ worth?
The government has obligated $74,636 on SPE2DB25FN3QQ.
Is contract SPE2DB25FN3QQ an order under another contract?
Yes. SPE2DB25FN3QQ is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3QQ competed?
The extent of competition for SPE2DB25FN3QQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award